Does Tretinoin Thin Skin? Retin-A Side Effects Explained

Few ingredients in skincare have earned as much praise—or caused as much confusion—as tretinoin (Retin-A). Dermatologists often describe it as the “gold standard” for anti-aging. Skincare forums are filled with dramatic before-and-after photos. And yet, for decades, scientists have quietly documented a paradox: tretinoin both thickens and thins the skin, depending on when you look.

This contradiction has left many consumers wondering:

In this article, I’ll walk you through the biology of tretinoin step by step. We’ll look at what happens in the “crazy phase” of early use, why those changes reverse over time, how fat cells are uniquely affected, and what all of this means for your skin’s long-term vitality.

This isn’t about demonizing tretinoin—it is about making sense of the evidence, much of which has been published in high-quality journals but rarely shared with the public. Understanding the full picture helps us make better choices, not just about tretinoin, but about how we approach skincare in general.

Key takeaway: The thickening effect of tretinoin is real—but temporary. Long-term, the evidence points in the opposite direction: thinning of both the epidermis and the dermis, and disruption of fat cell regeneration.

When people say “tretinoin thickens skin,” they are usually describing what happens in the first several months of use. At prescription strength, tretinoin delivers a pharmacologic flood of vitamin A that the skin has never encountered before. Cells react as if under siege, launching into a hyperactive remodeling response—a phase I often call the “crazy phase.”

During this period, two key processes occur:

The result is that around 3–6 months of tretinoin use, people often see dramatic before-and-after changes. Fine lines fade, pores appear smaller, and skin looks “tighter.” These are the images that dominate online forums and promotional literature.

But it is crucial to understand that this remodeling is not the same as natural regeneration. The collagen scaffold created under the influence of excessive levels of vitamin A is structurally abnormal and inherently unstable.

Key References

• Skincare Science: Update on Topical Retinoids. C.B. Boswell. 2006.
• Topical Tretinoin in the Management of Thick-skinned Rhinoplasty Patients. Hamidreza Rastiboroujeni. 2024.

The striking changes people notice in the first months of tretinoin use don’t last. After about a year, the skin adapts to the constant high-dose vitamin A exposure. The abnormal collagen scaffold that formed during the “crazy phase” is dismantled, and both the epidermis and dermis gradually become thinner than they were at baseline.

This long-term thinning helps explain why the literature on tretinoin looks so contradictory. If a study measures skin at 3 months, it shows thickening and collagen increase. If it measures at 12 months or later, the opposite is true.

Key References

• Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Siddharth Mukherjee. 2006.

Collagen has become a kind of shorthand for youth. Advertisements promise to “boost collagen,” while influencers praise any ingredient that “stimulates collagen production.” It is often treated as if collagen were a commodity—like money in a bank account—where more is always better.

But biology is not that simple. Collagen is less like cash and more like building materials. A stack of lumber is not valuable on its own—it is valuable only when assembled into a well-designed, stable structure.

During tretinoin’s “crazy phase,” fibroblasts pump out collagen in response to stress. But the collagen is laid down in a disorganized, chaotic pattern, forming a scaffold that does not resemble the natural architecture of healthy dermis.

This explains why short-term use can create the appearance of plumper, smoother skin: the temporary scaffold props up the tissue. But over time, the skin recognizes this scaffold as defective and dismantles it. What remains is not improved skin, but weakened structure.

The superficial gain of “more collagen” is misleading if the collagen is poorly constructed and short-lived. Healthy skin requires ongoing regeneration of small, metabolically active fat cells that keep fibroblasts balanced and collagen properly organized. Without that regenerative loop, collagen production cannot be sustained.

Another widely circulated claim about tretinoin is that it is beneficial because it “increases cell turnover.” This sounds positive—after all, faster turnover suggests fresher skin. But biology rarely rewards extremes.

• Early months: Keratinocytes divide and migrate upward more rapidly, creating visible peeling and flaking.
• Chronic use: The accelerated cycle leads to compaction. By 12 months, the epidermis is actually thinner than baseline.

What begins as “renewal” ultimately becomes erosion of reserves.

The very mechanism that gives tretinoin its reputation for brightness and smoothness—relentless exfoliation—also undermines the skin’s long-term defense system. For individuals struggling with hyperpigmentation disorders like melasma, this temporary melanin depletion may bring relief. But for the majority, it represents a net loss of resilience.

If the scientific record shows that tretinoin’s benefits are temporary and its long-term effects can thin the skin, reduce fat cell regeneration, and strip melanin, why is it still prescribed so widely and called the “gold standard” of anti-aging?

The answer lies less in biology and more in professional culture.

Tretinoin was approved for acne in 1971 and later promoted for photoaging in the 1980s and 90s. Early studies—conducted over a few months—showed collagen increase and epidermal thickening. These results were published in high-profile journals like the New England Journal of Medicine and became entrenched in dermatology training. Once a treatment is canonized in medical education, it tends to persist for decades, even as new evidence emerges.

Before-and-after photos taken at 3–6 months, during the “crazy phase,” are persuasive. The visible improvement in fine lines and surface texture sells the story, while the one-year follow-ups (which often show thinning and reversal) are rarely publicized.

Few dermatologists are eager to be the first to say, “We got it wrong.” To challenge a gold-standard treatment risks professional backlash. It is safer, socially and professionally, to continue the prevailing narrative—even when the literature suggests otherwise.

Pharmaceutical companies and skincare brands have invested heavily in the tretinoin story. Marketing emphasizes the temporary collagen surge and early before/afters, reinforcing the perception of lasting rejuvenation.

Key References

• 50 Years of Topical Retinoids for Acne: Evolution of Treatment. Hilary Baldwin. 2021.

One of the deepest misconceptions in skincare is that actives should be used every day, indefinitely. This belief has been reinforced by both dermatology protocols and beauty marketing, which encourage people to treat skincare like brushing their teeth—daily, lifelong, without pause.

But the skin is not a static surface. It is a dynamic ecosystem. And like any ecosystem, it does not thrive under constant overstimulation.

Think of topical actives as nutrients. A healthy diet includes a variety of foods, in the right amounts, at the right times. We don’t eat salmon three times a day, or sauerkraut with every meal, even though both are healthy. The same principle applies to the skin:

Instead of constant stimulation, skincare should focus on restoring regenerative balance. Use strong interventions as needed, then step back once the skin’s ecosystem has regained its natural rhythm. This approach not only preserves resilience but also minimizes the risk of side effects.

The science of tretinoin reveals a larger lesson about skincare: forcing the skin into overdrive is not the same as restoring vitality.

Tretinoin’s entire mechanism is based on overstimulation. Flood the skin with pharmacologic vitamin A, push keratinocytes and fibroblasts into hyperactivity, provoke inflammation, block fat cell maturation—and watch the temporary remodeling unfold. The results can look impressive at six months. But after a year, the cycle collapses: epidermis and dermis are thinner, fat cells are suppressed, fibroblasts are quieter, and the skin is weaker.

This “burnout model” of skincare is the opposite of what the skin truly needs.

At Adipeau, we start from a different premise:

We encourage people to use our cream until they see the results they want—and then step back. Maintenance can be minimal once regeneration is restored. This philosophy stands in contrast to the “daily forever” mindset that tretinoin promotes.

The story of tretinoin is one of contradictions hidden in plain sight.

This helps explain why dermatology has clung to tretinoin as the “gold standard.” The early effects are measurable and marketable. But the long-term biology tells a different story: thinning, fragility, and loss of regenerative capacity.

At Adipeau, we believe the better path is not to overdrive the skin into exhaustion, but to restore its natural rhythms of regeneration. Healthy fat cells, active fibroblasts, and balanced inflammation are the foundation of resilient, youthful skin. Support that cycle, and the skin sustains itself.

Final takeaway: Skincare should not be about “more stimulation.” It should be about better regeneration. Less is more, balance is stronger than force, and lasting vitality comes from restoring what the skin already knows how to do.